Real-life data on pasireotide in monotherapy or combined in active Cushing’s disease

IntroductionIn the last few years, the use of medical treatment in Cushing’s disease (CD) has increased thanks to the availability of new molecules. Nevertheless, real-life data on combination treatments are still lacking.MethodsThis is a retrospective monocentric study evaluating the real-life effi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Alessandro Mondin, Filippo Ceccato, Carla Scaroni, Luca Denaro, Renzo Manara, Umberto Maria Robertazzo, Mattia Barbot
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2025-11-01
Series:Frontiers in Endocrinology
Assuntos:
Cushing’s disease
somatostatin analogue
pasireotide
combination treatment
metyrapone
cabergoline
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fendo.2025.1695342/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares